NAD+ supplementation
1 paper
- Funder: National Heart, Lung, and Blood Institute
Funding
1 grant since 2022National Heart, Lung, and Blood InstituteUS$705.8k
Latest
Cell Death Discovery
Targeting NAD+: is it a common strategy to delay heart aging?
ReviewInterventions